Effects of extra virgin olive oil supplementation at two different low doses on lipid profile in mild hypercholesterolemic subjects: A randomised clinical trial

Journal of Endocrinological Investigation

Volumn 32, Issue 10, 2009, Pages 794-796

  Violante, B ^a   Gerbaudo, L ^a   Borretta, G ^b   Tassone, F ^b  

^a National Health Service   (Italy)

^b Division of Endocrinology and Metabolism   (Italy)

Author keywords

Apolipoprotein B; Cholesterol; Olive oil

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLIVE OIL; TRIACYLGLYCEROL;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; FAT INTAKE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MORNING DOSAGE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SCORING SYSTEM; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BLOOD PRESSURE; DIET, MEDITERRANEAN; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; MIDDLE AGED; PLANT OILS; PROSPECTIVE STUDIES; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC;

EID: 77349089277     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/6103     Document Type: Article

References (12)

1. Canosa A, Stracci F, Cassetti T, Minelli L, Romagnoli C, La Rosa F. Trends in mortality due to the main causes of death in Umbria (Italy), 1994-2004. Ig Sanita Pubbl 2006, 62: 463-74.
2. Centers for Disease Control and Prevention (CDC). Prevalence of heart disease - United States, 2005. MMWR Morb Mortal Wkly Rep 2007, 56: 113-8.
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285: 2486-97.
4. Walldius G, Jungner I. The apoB/apoA-1 ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence. J Intern Med 2006, 259: 493-519.
5. Keys A, Menotti A, Karvonen MJ, et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol 1986, 124: 903-15.
6. Perez-Jimenez F, Espino A, Lopez-Segura F, et al. Lipoprotein concentrations in normolipidemic males consuming oleic acid-rich diets from two different sources: olive oil and oleic acid-rich sunflower oil. Am J Clin Nutr 1995, 62: 769-75.
7. Sirtori CR, Tremoli E, Gatti E, et al. Controlled evaluation of fat intake in the Mediterranean diet: comparative activities of olive oil and corn oil on plasma lipids and platelets in high-risk patients. Am J Clin Nutr 1986, 44: 635-42.
8. Visioli F, Galli C. Antiatherogenic components of olive oil. Curr Atheroscler Rep 2001, 3: 64-7.
9. Beauchamp GK, Keast RS, Morel D, et al. Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature 2005, 437: 45-6.
10. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in the incidence of coronary heart disease. JAMA 1984, 251: 351-64.
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of a preparative ultracentrifuge. Clin Chem 1972, 18: 499-502.
12. Dobiásová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem 2001, 34: 583-8.